Norges Bank
PHAT icon

Norges Bank’s Phathom Pharmaceuticals PHAT Stock Holding History

Norges Bank’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-660,690
Closed -$8.99M – 2140
2022
Q1 		$8.99M Hold
660,690
– – ﹤0.01% 1742
2021
Q4 		$13M Buy
660,690
+331,347
+101% +$7.8M ﹤0.01% 1662
2021
Q3 		$10.6M Hold
329,343
– – ﹤0.01% 1747
2021
Q2 		$11.1M Hold
329,343
– – ﹤0.01% 1749
2021
Q1 		$12.4M Hold
329,343
– – ﹤0.01% 1729
2020
Q4 		$10.9M Buy
329,343
+70,000
+27% +$2.84M ﹤0.01% 1751
2020
Q3 		$9.51M Hold
259,343
– – ﹤0.01% 1729
2020
Q2 		$8.54M Hold
259,343
– – ﹤0.01% 1760
2020
Q1 		$6.7M Sell
259,343
-57,957
-18% -$1.94M ﹤0.01% 1750
2019
Q4 		$9.88M Buy
+317,300
New +$7.97M ﹤0.01% 1804

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Norges Bank's PHAT Position: Q2 2022 in Review

Norges Bank sold out of Phathom Pharmaceuticals (PHAT) in Q2 2022, closing a stake of 660,690 shares — an estimated $8.99M sold.

Norges Bank first reported a position in PHAT in Q4 2019 and held it in 10 quarters. The position peaked at $13M in Q4 2021. 94 funds tracked by Wall St. Rank hold PHAT as of Q2 2022.

  • Norges Bank reported no remaining Phathom Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 660,690 Phathom Pharmaceuticals shares in Q2 2022, an estimated $8.99M.
  • Norges Bank first reported a position in Phathom Pharmaceuticals in Q4 2019 and held it in 10 quarters.
  • Norges Bank's Phathom Pharmaceuticals position peaked at $13M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.